First Human Infection of Shamonda Virus Confirmed in France
A patient in Lyon has died from the Shamonda virus, marking the first human case ever recorded.
The Shamonda virus was first identified in Nigeria in the 1960s.
The infected patient was severely immunocompromised and treated for another serious illness.
Health authorities have ruled out any general health risk to the population.
French health officials have reported the first known human infection of the Shamonda virus, with the patient passing away in early October. This unprecedented case was confirmed in Lyon, where the individual was undergoing treatment for a severe illness. Authorities have stated that there is currently no identified health risk to the general public from this virus.
The Shamonda virus, which is primarily transmitted to animals through biting midges of the genus Culicoides, was first detected in Nigeria during the 1960s. It has since been sporadically reported in cattle across various regions in Africa and Japan. Despite its long history of circulation in these areas, this marks the first official documentation of human infection.
The patient, who had a severely weakened immune system, exhibited brain complications prior to death that preliminary investigations suggest were likely connected to the Shamonda virus. Health authorities believe that the infection was contracted from a midge bite in eastern France, highlighting the potential for zoonotic diseases to cross into human populations under certain conditions.
Officials have emphasized that this case is exceptional and pertains specifically to an individual with significant health vulnerabilities. They have communicated with the World Health Organization and the European Centre for Disease Prevention and Control to ensure proper monitoring and response to this rare occurrence.
Looking ahead, health authorities continue to assess the situation, maintaining vigilance for any potential cases while reassuring the public that there is no current risk of widespread transmission. Ongoing investigations will focus on understanding the virus's behavior and ensuring comprehensive public health measures are in place.
